CNA Financial Corporation
NYSE:CNAInsurance - Property & Casualty
-$0.24 today
- Market cap
- $13.12B
- Beta
- 0.32
- P/E (TTM)
- 9.2
- EPS (TTM)
- $4.91
- Dividend yield
- 8.57%
Volume 0.50M
Average 0.48M
CNA Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
CNA Financial CorporationNYSE: CNA
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents falls 25.5% from a year ago
Cash & equivalents stood at $360M at the end of Q3 FY2026, down 25.5% from a year earlier and up 6.2% from the prior quarter. Over 3 fiscal years it compounded at -3.6% a year.
Context
- Cash & equivalents amounted to 0.5% of total assets at the end of Q3 FY2026, down 0.2 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -25.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 425M USD
- Year-over-year change
- -10.0%
- 4-year CAGR
- -5.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 425M | -10.0% |
| FY2024 | 2024-12-31 | 472M | +36.8% |
| FY2023 | 2023-12-31 | 345M | -27.4% |
| FY2022 | 2022-12-31 | 475M | -11.4% |
| FY2021 | 2021-12-31 | 536M | — |
Cash & Equivalents vs competitors
How CNA compares with its peers on the latest reported figures
- CNA's Sep 2026 cash & equivalents of $360M is the 7th highest of the 11 companies compared; the peer median is $636.15M.
- Its year-over-year change of -25.5% is the 10th highest of 11, against a peer median of +3.9%.
- Cash & equivalents amounts to 0.5% of total assets for CNA, versus a peer median of 2.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $4.2B | -9.1% | -1.4% | 5.8% | |
| Sep 2026 | $3.01B | +34.3% | +4.1% | 1.1% | |
| Jun 2026 | $1.44B | +13.4% | +25.6% | 4.4% | |
| Sep 2026 | $1.24B | -15.1% | +4.2% | 2.9% | |
| Sep 2026 | $766M | +29.4% | -3.9% | 0.5% | |
| Sep 2026 | $506.3M | -44.7% | +54.4% | 3.0% | |
| Sep 2026 | $360M | -25.5% | -3.6% | 0.5% | |
| Sep 2026 | $336M | +38.6% | +48.1% | 1.5% | |
| Jun 2026 | $219.22M | +60.5% | +54.8% | 3.2% | |
| Sep 2026 | $160.51M | -5.7% | +1.5% | 2.5% | |
| Sep 2026 | $46.21M | -12.2% | +31.2% | 0.7% | |
| Peer median (excluding CNA) | $636.15M | +3.9% | +14.9% | 2.7% | |
Competitors are the stored peer set for CNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 536M | 475M | 345M | 472M | 425M |
| Short-term Investments | 0 | 0 | 0 | 0 | 3.71B |
| Net Receivables | 2.95B | 3.16B | 3.44B | 3.67B | 10.6B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 3.48B | 3.63B | 3.79B | 4.14B | 14.73B |
| Property, Plant & Equipment (Net) | 401M | 381M | 393M | 453M | 282M |
| Goodwill | 148M | 144M | 146M | 145M | 148M |
| Intangible Assets | 67M | 877M | 78M | 77M | 986M |
| Long-term Investments | 50.33B | 43.18B | 46.56B | 47.48B | 46.74B |
| Tax Assets | 654M | 1.46B | 1.28B | 1.22B | 575M |
| Other Non-current Assets | 6.61B | 7B | 7.32B | 7.29B | 5.98B |
| Total Non-current Assets | 58.21B | 52.16B | 55.77B | 56.67B | 54.71B |
| Total Assets | 61.69B | 55.79B | 59.56B | 60.81B | 69.44B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 42M | 243M | 586M | 43M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 5.76B | 6.37B | 6.93B | 7.35B | 7.64B |
| Other Current Liabilities | (5.86B) | (6.64B) | (7.55B) | (7.42B) | 30.74B |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 38.37B |
| Long-term Debt | 2.78B | 2.54B | 2.48B | 2.97B | 2.97B |
| Deferred Tax Liabilities | 512M | 210M | 261M | 371M | 0 |
| Deferred Revenue (Non-current) | 4.5B | 4.71B | 4.69B | 4.53B | 4.14B |
| Other Non-current Liabilities | 40.88B | 39.56B | 42.05B | 42.23B | 12.34B |
| Total Non-current Liabilities | 48.88B | 47.25B | 49.67B | 50.3B | 19.45B |
| Total Liabilities | 48.88B | 47.25B | 49.67B | 50.3B | 57.82B |
| Common Stock | 683M | 683M | 683M | 683M | 683M |
| Retained Earnings | 9.66B | 9.34B | 9.76B | 9.69B | 9.92B |
| Accumulated OCI | 320M | (3.6B) | (2.67B) | (1.99B) | (1.1B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 12.81B | 8.55B | 9.89B | 10.51B | 11.62B |
| Total Debt | 3.03B | 3B | 3.25B | 3.21B | 2.97B |
| Net Debt | 2.49B | 2.53B | 2.9B | 2.74B | 2.55B |
CNA Financial Corporation
NYSE:CNA
Intrinsic Alpha fair value
Locked
Current Price
$48.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.